Related Experiment Videos
[Pacemaker lead implant via the persistent left superior vena cava]
Jairo Armando Rodríguez-Fernández1, Arturo Almazán-Soo
1Servicio de Cardiología Hospital General de Zona Núm. 24, IMSS, México DF, México. jairo_r@doctor.com
Archivos De Cardiologia De Mexico
|December 22, 2005
Summary
Persistent left superior vena cava (PLSVC) is a rare anomaly often discovered during pacemaker implantation. Awareness of PLSVC is crucial for successful lead placement and patient management.
Area of Science:
- Cardiovascular Medicine
- Medical Imaging
- Anatomy
Background:
- Persistent left superior vena cava (PLSVC) is an uncommon congenital vascular anomaly affecting 0.5% of the population.
- It is typically asymptomatic and often discovered incidentally during procedures requiring central venous access, such as pacemaker implantation.
- PLSVC can present significant challenges for transvenous lead placement, particularly when using the left subclavian vein approach.
Observation:
- A case of a 26-year-old woman with Sick Sinus Syndrome where PLSVC was unexpectedly identified during pacemaker lead implantation.
- The anomalous venous structure was suspected due to the medial positioning of the lead, confirmed by venography showing drainage into the coronary sinus.
- Successful pacemaker implantation was achieved with the lead positioned in the right atrium.
Findings:
- PLSVC is a rare congenital abnormality that can be associated with cardiac rhythm disturbances.
- The anomaly can complicate the positioning of pacemaker and cardioverter-defibrillator leads, especially with left-sided approaches.
- Operators must be aware of PLSVC to navigate challenges in transvenous lead implantation.
Implications:
- Knowledge of PLSVC anatomy and potential complications is vital for interventional cardiologists and electrophysiologists.
- Alternative venous access or epicardial implantation may be necessary in cases of difficult coronary sinus cannulation.
- Understanding PLSVC is also relevant for other specialties utilizing transvenous catheters, including critical care and nephrology.